Astria Therapeutics Stock (NASDAQ: ATXS) stock price, news, charts, stock research, profile.
You can purchase shares of Astria Therapeutics (NASDAQ:ATXS) through any online brokerage.
Other companies in Astria Therapeutics’s space includes: Sage Therapeutics (NASDAQ:SAGE), aTyr Pharma (NASDAQ:ATYR), PureTech Health (NASDAQ:PRTC), Monte Rosa Therapeutics (NASDAQ:GLUE) and Olema Pharmaceuticals (NASDAQ:OLMA).
Astria Therapeutics has a consensus price target of $24.57.
The stock price for Astria Therapeutics (NASDAQ: ATXS) is $6.82 last updated February 20, 2025 at 4:00 PM EST.
There are no upcoming dividends for Astria Therapeutics.
Astria Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for Astria Therapeutics.
Astria Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.